glp-1 weight loss drugs tirzepatide semaglutide for Loss: Every Option Compared Tirzepatide vs. Semaglutide: Which Weight

GLP-1 agonists and DPP-4 inhibitors were the sole antihyperglycemic agents reported in 46.6% and 25.4% of the cases, respectively

However, this remains challenging for many obese individuals

See the related article at Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake

Since that analysis recruited participants from a single neuro-ophthalmology practice (Massachusetts Eye and Ear in Boston), a separate team of researchers questioned whether these findings apply to broader populations

Semaglutide and diabetic retinopathy: An OHDSI network study

Int J Mol Sci 19:3331